FDA Clearance Tracker · K221358
Isolator® Linear Pen (MLP1); Isolator® Transpolar Pen (MAX1, MAX5), Coolrail® Linear Pen (MCR1); Isolator® Synergy Surgical Ablation System (EMR2, EML2); Isolator® Synergy EnCompass Clamp (OLH, OSH) and Guide System; Isolator® Synergy Access Clamp (EMT1)
Last checked: Nov 20, 2026Latest source record: Dec 30, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Dec 30, 2022
Substantially Equivalent
Time to decision
233 days
Received May 11, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K221358
- Device name
- Isolator® Linear Pen (MLP1); Isolator® Transpolar Pen (MAX1, MAX5), Coolrail® Linear Pen (MCR1); Isolator® Synergy Surgical Ablation System (EMR2, EML2); Isolator® Synergy EnCompass Clamp (OLH, OSH) and Guide System; Isolator® Synergy Access Clamp (EMT1)
- Applicant
- AtriCure, Inc.
- Applicant location
- Mason, OH
- Received
- May 11, 2022
- Decided
- Dec 30, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL)
- Device class
- Class II
- Regulation
- 21 CFR 878.4400
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OCL. The earliest in FDA's data is K970496, decided May 9, 1997.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K221358
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for AtriCure, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263319 · Decided Oct 21, 2026 · 30 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
K252056 · Decided Jul 24, 2025 · 23 days after receipt
Device type: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue (OCL) · General & Plastic Surgery
K250371 · Decided Apr 10, 2025 · 59 days after receipt
Device type: Device, Surgical, Cryogenic (GXH) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.